IGPH.SW
IGEA Pharma NV
Price:  
0.00 
CHF
Volume:  
2,033,000.00
Netherlands | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IGPH.SW WACC - Weighted Average Cost of Capital

The WACC of IGEA Pharma NV (IGPH.SW) is 4.4%.

The Cost of Equity of IGEA Pharma NV (IGPH.SW) is 4.80%.
The Cost of Debt of IGEA Pharma NV (IGPH.SW) is 5.00%.

Range Selected
Cost of equity 3.30% - 6.30% 4.80%
Tax rate 16.80% - 18.00% 17.40%
Cost of debt 5.00% - 5.00% 5.00%
WACC 3.9% - 4.8% 4.4%
WACC

IGPH.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta -0.03 0.31
Additional risk adjustments 2.5% 3.0%
Cost of equity 3.30% 6.30%
Tax rate 16.80% 18.00%
Debt/Equity ratio 2.09 2.09
Cost of debt 5.00% 5.00%
After-tax WACC 3.9% 4.8%
Selected WACC 4.4%